Law ❯ Litigation ❯ Securities Litigation

Class Action

Investor Rights Shareholder Rights Fraud Securities Fraud Investor Protection Fraud Cases Corporate Fraud Applied Therapeutics, Inc. Zeta Global Holdings Corp. Lead Plaintiff Selection

3 ARTICLES

4d ago

Securities Suit Targets Peabody Over Centurion Ramp‑Up Disclosures

Plaintiffs say withheld information about commissioning and mechanical problems at Peabody’s Centurion mine inflated the stock and could shape who leads the investor class.

8 ARTICLES

2w ago

Law Firms Invite Lufax Investors to Seek Lead Plaintiff Role Before May 20 Deadline

3 ARTICLES

2mo ago

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

3 ARTICLES

2mo ago

Medpace Investors Invited to Seek Lead Role in Securities Suit by June 8

5 ARTICLES

2mo ago

Law Firms Urge Vital Farms Investors to Seek Lead Role in ERP-Related Securities Suits

7 ARTICLES

2mo ago

ImmunityBio Investors Face May 26 Deadline to Seek Lead Role in Securities Case

6 ARTICLES

2mo ago

Eos Energy Investors Face May 5 Deadline in Securities Case Over Factory Setbacks

8 ARTICLES

2mo ago

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

4 ARTICLES

2mo ago

UniQure Investors Face Lead‑Plaintiff Deadline in Securities Fraud Case

7 ARTICLES

3mo ago

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

12 ARTICLES

3mo ago

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

6 ARTICLES

4mo ago

Ardent Health Investors Urged to Seek Lead Role Before March 9 in Securities Class Action

4 ARTICLES

4mo ago

Richtech Robotics Faces Securities Class Action Over Microsoft Tie as Firms Seek Lead Plaintiff

3 ARTICLES

4mo ago

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

5 ARTICLES

4mo ago

Class Action

Securities Suit Targets Peabody Over Centurion Ramp‑Up Disclosures

Investors File Lawsuits After GeneDx's 94% Write‑Down and 49% Stock Plunge

Class Actions Filed Over PicS IPO Credit Disclosures

Plaintiff Firms Race to Lead Securities Suit Against Sportradar

Investors Vie to Lead ImmunityBio Securities Suit

ImmunityBio Securities Fight Intensifies After FDA Rebuke Over Anktiva Claims

Law Firms Invite Lufax Investors to Seek Lead Plaintiff Role Before May 20 Deadline

Rosen Law Reminds Stellantis Investors of June 8 Deadline to Seek Lead Role in Securities Suit

Medpace Investors Invited to Seek Lead Role in Securities Suit by June 8

Law Firms Urge Vital Farms Investors to Seek Lead Role in ERP-Related Securities Suits

Never miss stories about

Class Action

ImmunityBio Investors Face May 26 Deadline to Seek Lead Role in Securities Case

Eos Energy Investors Face May 5 Deadline in Securities Case Over Factory Setbacks

Investor Lawsuits Build After FDA Rebukes ImmunityBio Over Anktiva Promotion

UniQure Investors Face Lead‑Plaintiff Deadline in Securities Fraud Case

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

Navan Faces Securities Class Action Over IPO Disclosures as Lead-Plaintiff Push Builds

Ardent Health Investors Urged to Seek Lead Role Before March 9 in Securities Class Action

Richtech Robotics Faces Securities Class Action Over Microsoft Tie as Firms Seek Lead Plaintiff

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

F5 Investors Face Feb. 17 Deadline in Securities Class Action Over Alleged Breach Misstatements

Never miss stories about

Class Action